Novel Strategies to Advance Biotherapeutic Development

Symposium: Development Strategy for Novel Targeted Therapeutic Delivery

Moderator(s)

• 

  Lynn Kamen, PhD

  Scientific Officer
  BioAgilytix Labs
  Durham, North Carolina

Presentations:

• 9:30 AM – 10:00 AM PT

  An Ultra-Sensitive Human pS413 Tau Assay in Cerebrospinal Fluid
  

  Speaker: Xuemei Zhao, PhD – Merck
• 10:00 AM – 10:30 AM PT

  The Advancement of High-Plex Bioanalytical Technology and its Data Integration
  

  Speaker: Tomoki Yamashita, PhD (he/him/his) – Takeda Pharmaceutical Company Limited
• 10:30 AM – 11:00 AM PT

  Hybrid LBA LC-MS Assay: Does One Size Fit All?
  

  Speaker: Jinhui Zhang, PhD (he/him/his) – US Food and Drug Administration